Header
Header
Article

New patent for Deciphera Pharms drug QINLOCK – DrugPatentWatch


Copyright © DrugPatentWatch. Originally published at New patent for Deciphera Pharms drug QINLOCK


Annual Drug Patent Expirations for QINLOCK

Qinlock is a drug marketed by Deciphera Pharms and is included in one NDA. It is available from one supplier. There are ten patents protecting this drug.

This drug has sixty-one patent family members in thirteen countries.

The generic ingredient in QINLOCK is ripretinib. One supplier is listed for this compound. Additional details are available on the ripretinib profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at New patent for Deciphera Pharms drug QINLOCK



Source link

Back to top button